Aratana Therapeutics to Report First Quarter 2019 Financial Results

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, will report financial results from the first quarter ended March 31, 2019 on Wednesday, May 8.

Recent News Posts

View All

Aratana Therapeutics to be Acquired by Elanco Animal Health

The Company announced it has signed an agreement to be acquired by Elanco Animal Health (NYSE: ELAN), its global collaboration partner on GALLIPRANT® (grapiprant tablets). In conjunction with the transaction, Elanco also announced the formation of a commercial team dedicated to the veterinary specialty business. If the proposed agreement is consummated, the Aratana field force would transition into this commercial team.